Magnesium supplementation significantly reduces serum S100β concentrations in patients who have undergone coronary artery bypass surgery

Magnesium Research

Volumn 22, Issue 1, 2009, Pages 21-31

  Dabrowski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CABG; Dobutamine; Dopamine; Extracorporeal circulation; Magnesium; Magnesium supplementation; S100

Indexed keywords

DOBUTAMINE; DOPAMINE; MAGNESIUM; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; BLOOD; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; DOBUTAMINE; DOPAMINE; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 66149084789     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0156     Document Type: Article

References (38)

1. Feng D, Zhu Z, Lu Y. Effect of magnesium sulfate on traumatic brain edema in rats. Chin J Traumatol 2004; 7: 148-52.
2. Health DL, Vink R. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharm Exp Therap 1999; 288: 1311-6.
3. Muir KW. Magnesium in stroke treatment. Postgrad Med J 2002; 78: 641-5.
4. Muir KW, Lees KR. Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke 1998; 29: 918-23.
5. Chi OZ, Pollak P, Weiss HR. Effect of magnesium sul- fate and nifedipine on regional cerebral blood flow dur- ing middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 1990; 304: 196-205.
6. Liu Y, Zhang J. Recent development in NMDA recep- tors. Chin Med J (Engl) 2000; 113: 948-56.
7. Mayer ML, Westbrook GL, Guthrie PB. Voltage- dependent block by Mg+2 of NMDA responses in spinal cord neurons. Nature 1984; 309: 261-3.
8. Ebel H, Gunther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem 1980; 18: 257-70.
9. Sotaniemi KA. Long-term neurological outcome after cardiac operation. Ann Thorac Surg 1995; 59: 1336-9.
10. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longi- tudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 2001; 344: 395-402.
11. Wolman RL, Nussmeier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman M, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischaemia Research Education Foundation (IREF). Investigators Stroke 1999; 30: 514-22.
12. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function and expression. Brain Res Bull 1995; 37: 417-29.
13. Haglid K, Yang Q, Hamberger A, Bergman S, Wider- berg A, Danielson N. S100β stimulates neurite out- growth in the rat sciatic nerve grafted with a cellular muscle transplants. Brain Res 1997; 753: 196-201.
14. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 15: 540-51.
15. Westaby S, Johnson P, Parry AJ, Blomqvist S, Solem JO, Ailing C, et al. Serum S100 protein, a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 88-92.
16. Goncalves CA, Concli Leite M, Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008; 41: 755-63.
17. Kleindienst A, Hesse F, Bullock MR, Buchfelder M. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 2007; 161: 317-25.
18. Jonsson H. S100β and cardiac surgery. Possibilities and limitations. Rest Neurol Neurosd 2003; 21: 151-7.
19. Jönsson H, Johnsson P, Bäckstrom M, Ailing C, Dautovic-Bergh C, Blomqvist S. Controversial signifi- cance of early S100β levels after cardiac surgery. BMC Neurol 2004; 4: 24-31.
20. Dabrowski W. Do changes in S100β protein correlate with serum magnesium concentrations in patients undergoing extracorporeal circulation? Magnes Res 2007; 20: 168-76.
21. Takahashi M, Chamczuk A, Hong Y, Jackowski G. Rapid and sensitive immunoassay for the measure- ment of serum S100β using isoform-specific monoclo- nal antibody. Clin Chem 1999; 45: 1307-11.
22. Snyder-Ramos SA, Gruhlke T, Bauer M, Luntz AP, Motsch J, Martin E, et al. Cerebral and extracerebral release of protein S100β in cardiac surgical patients. Anaesthesia 2004; 59: 344-9.
23. Whitaker DC, Green AJ, Stygall J, Harroson MJ, New- man SP. Evaluation of an alternative S100β assay for use in cardiac surgery: relationship with microemboli and neuropsychological outcome. Perjusion 2007; 22: 267-72.
24. Anderson RE, Hansson LO, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker SlOObeta after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 847-50.
25. Jönsson H, Johnsson P, Ailing C, Bäckstrom M, Bergh C, Blomqvist S. SlOObeta after coronary artery surgery: release pattern, source of contamination and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202-8.
26. Brooker RF, Brown WE, Moody DM, Hammon JW, Reboussian DM, Deal DD, et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopul- monary bypass. Ann Thorac Surg 1998; 65: 1651-5.
27. Herrmann M, Ebert AD, Galazky I, Wunderlich MT, Kunz WS, Huth C. Neurobehavioral outcome predic- tion after cardiac surgery. Role of neurochemical mar- kers of damage to neuronal and glial brain tissue. Stroke 2000; 31: 645-50.
28. Kilminster S, Treasure T, McMillan T, Holt DW. Neuro- psychological change and S100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke 1999; 30: 1869-74.
29. Muir KW, Lees KR. A randomized, double-blind, placebo-controlled pilot trial of intrasvenous magne- sium sulfate in acute stroke. Stroke 1995; 26: 1183-8.
30. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Har- baugh RE. Neuroprotective effect of preischemia intra- arterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-24.
31. Bhudia SK, Cosgrove DM, Naugle IR, Rajewswaran J, Lam B-K, Walton E, et al. Magnesium as a neuroprotec- tant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2006; 131: 853-61.
32. Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D. Peripheral markers of blood-brain barrier damage. Clin Chim Acta 2004; 342: 1-12.
33. 2 in closed head injury: a comparative phos- phorus NMR study. J Neurotrauma 1998; 15: 161-6.
34. Harris DNF, Bailey SM, Smith PLC, Taylor KMT, Oatridge A, Bydder GM. Brain swelling in first hour after coronary artery bypass surgery. Lancet 1993; 342: 586-7.
35. Wolman RL, Nussmeir NA, Aggrawal A, Kanchuger MS, Roach GW, Newman MF, et al, Multicenter Study of Perioperative Ischemia (McSPI) Research Group and Ischemia Research and Education Founda- tion (IREF) Investigator. Cerebral injury after cardiac surgery. Identification of a group at extraordinary risk. Stroke 1999; 30: 514-22.
36. Rolfson DB, McElhaney JE, Rockwood K, Finnegan BA, Entwistle LM, Wong JF, et al. Incidence and risk factors for delirium and other adverse outcomes in older adults after coronary artery bypass graft surgery. Can J Cardiol 1999; 15: 771-6.
37. O'Neill MJ, Hicks CA, Ward MA, Cardwell GP, Rey- mann JM, Allain H, et al. Dopamine D2 receptor ago- nists protect against ischemia-induced hippocampal neurodegeneration in global cerebral ischemia. Eur J Pharmacol 1998; 352: 37-46.
38. Park WS, Chang YS, Shim JW, Kim MJ, Ko SY, Kim SS, et al. Effect of dopamine infusion on cerebral blood flow, brain cell membrane function and energy metab- olism in experimental Escherichia coli meningitis in the piglet. J Korean Med Sci 2003; 18: 869-75.